Literature DB >> 23517020

Influence of CYP2C19*2 and *3 loss-of-function alleles on the pharmacodynamic effects of standard- and high-dose clopidogrel in East Asians undergoing percutaneous coronary intervention: the results of the ACCEL-DOUBLE-2N3 study.

Y-H Jeong, K A Abadilla, U S Tantry, Y Park, J-S Koh, C H Kwak, J-Y Hwang, P A Gurbel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23517020     DOI： 10.1111/jth.12200

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  6 in total

Review 1.  The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Authors:  Yao Yang; Joshua P Lewis; Jean-Sébastien Hulot; Stuart A Scott
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-07-14       Impact factor: 4.481

2.  "East asian paradox": challenge for the current antiplatelet strategy of "one-guideline-fits-all races" in acute coronary syndrome.

Authors:  Young-Hoon Jeong
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

Review 3.  Role of genetic testing in patients undergoing percutaneous coronary intervention.

Authors:  Jae Youn Moon; Francesco Franchi; Fabiana Rollini; Jose R Rivas Rios; Megha Kureti; Larisa H Cavallari; Dominick J Angiolillo
Journal:  Expert Rev Clin Pharmacol       Date:  2017-10-12       Impact factor: 5.045

Review 4.  Ethnic Differences in Oral Antithrombotic Therapy.

Authors:  Haechan Cho; Jeehoon Kang; Hyo Soo Kim; Kyung Woo Park
Journal:  Korean Circ J       Date:  2020-08       Impact factor: 3.243

5.  Frequency distribution of polymorphisms of CYP2C19, CYP2C9, VKORC1 and SLCO1B1 genes in the Yakut population.

Authors:  Filipp Filippovich Vasilyev; Diana Aleksandrovna Danilova; Vladimir Sergeevich Kaimonov; Yana Valerievna Chertovskih; Nadezda Romanovna Maksimova
Journal:  Res Pharm Sci       Date:  2016 May-Jun

6.  Effectiveness and safety of high dose clopidogrel plus aspirin in ischemic stroke patients with the single CYP2C19 loss-of-function allele: a randomized trial.

Authors:  Hongliang Wu; Huiqun Song; Lianwei Dou; Bo Gao; Yan Pan; Mei Dong; Qi Chen; Jiazhen Li; Lixiang Song; Chuanyu Liu; Bing Li; Wenzheng Chu
Journal:  BMC Neurol       Date:  2020-10-29       Impact factor: 2.474
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.